Q1 2026 Financial Performance and Product Highlights of 27 Leading Global MedTech Companies Including Medtronic and Johnson & Johnson

Note: The fiscal years of major companies do not necessarily align with the calendar year, resulting in discrepancies between fiscal quarters/years and their calendar counterparts. Companies may report financial performance on a quarterly or semi-annual basis.

Medical Devices and Diagnostics

Medtronic Reports Fourth Quarter and Fiscal Year Results for the Period Ended April 24, 2026. Net sales in the fourth fiscal quarter amounted to $9.807 billion, compared to $8.927 billion in the same period last year. Quarterly operating profit was $1.873 billion100 millionUSD, compared to USD 1.436 billion in the same period last year. The quarterly net profit attributable to the company was USD 1.243 billion, compared to USD 1.057 billion in the same period last year. The fiscal year's net sales were USD 36.364 billion, compared to USD 33.537 billion in the previous year. The fiscal year's operating profit was USD 6.467 billion, compared to USD 5.955 billion in the previous year. The fiscal year's net profit attributable to the company was USD 4.801 billion, compared to USD 4.662 billion in the previous year.

Johnson & Johnson Announces First-Quarter 2026 Results. Quarterly sales reached $24.062 billion, compared to $21.893 billion in the same period last year, representing a 9.9% year-over-year increase. Among these, Innovative Medicine sales amounted to $15.426 billion, up 11.2% year over year. MedTech sales totaled $8.636 billion, an increase of 7.7% year over year. Quarterly net income was $5.235 billion, down 52.4% from $10.999 billion in the same period last year.

Abbott Reports First-Quarter 2026 Results. Net sales for the quarter totaled $11.164 billion, compared to $10.358 billion in the same period last year, representing a year-over-year increase of 7.8%. Operating profit for the quarter was $1.345 billion, down 20.6% from $1.693 billion in the same period last year. Net income for the quarter amounted to $1.077 billion, a decrease of 18.7% from $1.325 billion in the same period last year. By segment, sales were $5.539 billion for Medical Devices, $2.18 billion for Diagnostics, $2.017 billion for Nutrition, and $1.426 billion for Pharmaceuticals.

Medline Reports First Quarter 2026 Results. Quarterly net sales were $7.352 billion, compared to $6.644 billion in the same period last year, representing a year-over-year increase of 10.7%. Quarterly operating profit was $422 million, down 26.1% from $571 million in the same period last year. Quarterly net income was $239 million, a 25.8% decrease from $322 million in the same period last year.

Siemens Healthineers Announces Second-Quarter Fiscal 2026 Results for the Period Ended March 31, 2026Siemens Healthineers announced its financial results for the second fiscal quarter ended March 31, 2026. Quarterly revenue amounted to €5.681 billion (approximately $6.61 billion), compared to €5.909 billion in the same period of the previous year. Adjusted quarterly EBIT was €836 million, down from €982 million in the prior-year period. Quarterly net profit stood at €512 million, compared to €537 million in the same quarter of the previous year.

Stryker Announces First Quarter 2026 Financial Results. Quarterly net sales were $6.02 billion, compared to $5.866 billion in the same period last year, representing a year-over-year increase of 2.6%. Quarterly operating profit was $936 million, compared to $837 million in the same period last year, a year-over-year increase of 11.8%. Quarterly net income was $745 million, compared to $654 million in the same period last year, a year-over-year increase of 13.9%.

Danaher Announces First-Quarter 2026 Results. Quarterly sales were $5.951 billion, compared to $5.741 billion in the same period last year. Quarterly operating profit was $1.344 billion, compared to $1.274 billion in the same period last year. Quarterly net income was $1.029 billion, compared to $954 million in the same period last year.

Fresenius Medical Care, Germany’s Leading Dialysis Provider, Announces Q1 2026 Results. Quarterly revenue amounted to €4.612 billion (approximately $5.364 billion), down 6% year-over-year from €4.881 billion in the same period last year. Operating profit totaled €286 million, a 14% decline from €331 million in the prior-year period. Net income reached €118 million, representing a 22% decrease compared to €151 million in the same quarter of the previous year.

Boston Scientific Reports First-Quarter 2026 Results. Quarterly sales were $5.286 billion, compared to $4.561 billion in the same period last year. Quarterly operating profit was $825 million, compared to $675 million in the same period last year. Quarterly net income attributable to common shareholders was $672 million, compared to $566 million in the same period last year.

GE HealthCare Reports First-Quarter 2026 Results. Total quarterly revenue amounted to $5.131 billion, compared to $4.777 billion in the same period last year. Quarterly operating profit was $515 million, down from $629 million in the prior-year period. Net income attributable to the company for the quarter stood at $389 million, compared to $564 million in the same period last year.

BD Reports Second-Quarter Results for the Period Ended March 31, 2026. Quarterly revenue amounted to $4.714 billion, compared to $4.48 billion in the same period last year, representing a year-over-year increase of 5.2%. Quarterly operating profit was $93 million, down 75.6% from $383 million in the same period last year. The company reported a net loss of $311 million for the quarter, compared to a net profit of $308 million in the same period last year.

Philips Reports First-Quarter 2026 Results. Quarterly sales amounted to €3.905 billion (approximately $4.54 billion), compared to €4.097 billion in the same period last year. Operating profit reached €241 million, up from €154 million a year earlier. Net income totaled €146 million, compared to €72 million in the prior-year period.

Roche Announces First-Quarter 2026 Results. Group sales for the quarter totaled CHF 14.722 billion, compared with CHF 15.44 billion in the same period last year. Of this, pharmaceuticals sales amounted to CHF 11.469 billion, versus CHF 11.949 billion a year earlier. Diagnostics sales reached CHF 3.253 billion (approximately USD 4.13 billion), compared with CHF 3.491 billion in the prior-year period.

Thermo Fisher Scientific Announces First Quarter 2026 Results. Quarterly revenue was $11.005 billion, compared to $10.364 billion in the same period last year. Quarterly operating profit was $1.863 billion, compared to $1.716 billion in the same period last year. Quarterly net income attributable to the company was $1.651 billion, compared to $1.507 billion in the same period last year. Among these, Life Sciences Solutions revenue was $2.626 billion, Laboratory Products and Biopharma Services revenue was $6.036 billion, Specialty Diagnostics revenue was $1.142 billion, and Analytical Instruments revenue was $1.716 billion.

Henry Schein Announces First Quarter 2026 Results. Net sales for the quarter were $3.368 billion, compared to $3.168 billion in the same period last year. Operating profit for the quarter was $182 million, compared to $175 million in the same period last year. Net income attributable to the company for the quarter was $107 million, compared to $110 million in the same period last year.

Cardinal Health Reports Third-Quarter Fiscal 2026 Results Ended March 31, 2026Cardinal Health announced its financial results for the third fiscal quarter ended March 31, 2026. Revenue for the quarter totaled $60.94 billion, with operating profit of $509 million and net income attributable to the company of $399 million. Within this, the Medical Products and Distribution segment reported quarterly revenue of $3.148 billion and profit of $25 million.

Intuitive Surgical, the provider of the “da Vinci” surgical robot system, announced its financial results for the first quarter of 2026. Total revenue for the quarter amounted to $2.771 billion, compared to $2.253 billion in the same period last year. Operating profit for the quarter reached $855 million, up from $578 million in the same period last year. Net profit attributable to the company for the quarter was $822 million, compared to $698 million in the same period last year.

Baxter International Announces First Quarter 2026 Results. Quarterly net sales were $2.701 billion, compared to $2.625 billion in the same period last year. Quarterly operating profit was $66 million, compared to $58 million in the same period last year. Quarterly net loss attributable to company shareholders was $15 million, compared to a net profit of $126 million in the same period last year.

Zimmer Biomet Holdings Announces First Quarter 2026 Results. Quarterly net sales were $2.087 billion, compared to $1.909 billion in the same period last year. Quarterly operating profit was $373 million, compared to $292 million in the same period last year. Quarterly net income was $238 million, compared to $182 million in the same period last year.

Solventum Announces First Quarter 2026 Results. Quarterly net sales were $2.007 billion, compared to $2.07 billion in the same period last year. Quarterly operating profit was $81 million, compared to $152 million in the same period last year. Quarterly net income was $13 million, compared to $137 million in the same period last year.

Terumo Announces Fiscal Year Results for the Year Ended March 31, 2026. Full-year revenue amounted to JPY 1131.877 billion (approximately USD 7.08 billion), compared to JPY 1036.171 billion in the previous year, representing a year-on-year increase of 9.2%. Full-year operating profit reached JPY 176.32 billion, up from JPY 157.668 billion in the prior year, a year-on-year increase of 11.8%. Full-year net profit attributable to owners of the parent company totaled JPY 135.914 billion, compared to JPY 116.978 billion in the previous year, marking a year-on-year increase of 16.2%.

Olympus Announces Fiscal Year Results Ended March 31, 2026Olympus Corporation announced its financial results for the fiscal year ended March 31, 2026. Full-year revenue amounted to ¥1,010.676 billion (approximately $6.322 billion), representing a 1.3% year-over-year increase from ¥997.332 billion in the previous fiscal year. Operating profit for the full year was ¥97.12 billion, a 40.2% year-over-year decrease from ¥162.462 billion in the prior year. Net profit attributable to owners of the parent company totaled ¥68.172 billion, marking a 42.2% year-over-year decline from ¥117.855 billion in the preceding fiscal year.

Fujifilm Holdings Announces Fiscal Year Results for the Period Ended March 31, 2026For the full fiscal year, revenue totaled JPY 335.6969 billion, up 5% year-on-year from JPY 319.5828 billion in the previous year. Operating profit for the year amounted to JPY 35.021 billion, representing a 6.1% increase from JPY 33.0155 billion in the prior year. Net income attributable to the company reached JPY 27.6735 billion, a 6% increase compared to JPY 26.0951 billion in the previous year.By business segment, the Healthcare sector generated revenue of JPY 109.89 billion (approximately USD 6.874 billion), a year-on-year increase of 4.9%. The Electronic Materials business recorded revenue of JPY 45.62 billion, up 11.9% year-on-year. The Imaging business achieved revenue of JPY 62.71 billion, marking a 15.7% year-on-year growth. Revenue from the Business Innovation segment was JPY 117.48 billion, a 2% year-on-year decline.

Canon Group Announces First-Quarter 2026 Financial ResultsThe Canon Group reported net sales of JPY 1,093.653 billion for the first quarter, representing a 3.3% year-on-year increase from JPY 1,058.396 billion in the same period last year. Operating profit amounted to JPY 71.37 billion, a 26.1% year-on-year decrease from JPY 96.517 billion. Net income attributable to the company totaled JPY 48.303 billion, down 33.1% from JPY 72.231 billion in the corresponding period of the previous year. By business segment, net sales were as follows: Printing Business Unit, JPY 610.504 billion; Medical Business Unit, JPY 142.067 billion (approximately USD 889 million); Imaging Business Unit, JPY 245.886 billion; and Industrial Business Unit, JPY 66.965 billion.

Ophthalmology

Eyewear Giant EssilorLuxottica Announces First-Quarter 2026 Results. Total quarterly revenue reached €7.127 billion, compared to €6.848 billion in the same period last year. Among this, revenue from the Professional Solutions business amounted to €3.362 billion, up from €3.226 billion (approximately $3.91 billion) in the prior-year period. Revenue from the Consumer Business stood at €3.764 billion, compared to €3.612 billion in the same period last year.

Alcon Announces First Quarter 2026 Results. Quarterly net sales were $2.685 billion, compared to $2.451 billion in the same period last year. Quarterly operating profit was $292 million, compared to $468 million in the same period last year. Quarterly net income attributable to shareholders was $189 million, compared to $350 million in the same period last year.

Bausch+Lomb Announces First Quarter 2026 Results. Quarterly revenue amounted to $1.244 billion, compared to $1.137 billion in the same period last year. Quarterly operating profit was $33 million, compared to an operating loss of $83 million in the same period last year. The net loss attributable to the company for the quarter was $71 million, compared to a net loss of $212 million in the same period last year.